What is the HRT window of opportunity?

It's the period - generally under age 60 or within 10 years of your final period - during which starting hormone therapy is associated with the most favorable balance of symptom relief and cardiovascular risk, based on re-analysis of WHI data and later research.

Is 60 too old to start HRT?

Sixty isn't an automatic cutoff, but it's the age most guidance uses as one edge of the favorable window. Starting after 60 doesn't rule out hormone therapy, but it does mean a doctor will weigh cardiovascular and other risk factors more carefully before prescribing.

What happens if you start HRT late?

Starting more than about 10 years after menopause is associated with a less favorable cardiovascular risk profile than starting earlier, based on the timing hypothesis research. It doesn't mean HRT is off the table, but the decision needs more individualized review of your health history.

Does timing matter for starting HRT?

Written and edited by the Peryla team. Last reviewed August 2026. Educational information, not medical advice.

Yes, timing matters. Research since the original 2002 WHI study has consistently found that starting hormone therapy under age 60, or within about 10 years of your final period, is associated with a more favorable balance of benefits and risks than starting later. This is often called the timing hypothesis or the window of opportunity.

It's not a hard cutoff where HRT flips from safe to dangerous overnight - it's a gradient, and the FDA's 2025-2026 label updates now build age-specific guidance into the prescribing information for the first time.

Where the timing hypothesis comes from

The original WHI trial pooled women aged 50 to 79, with an average age of 63. When researchers later broke the results down by age and years since menopause, a pattern emerged: women who started hormone therapy closer to menopause had markedly better cardiovascular outcomes than women who started a decade or more afterward. Follow-up studies, including later WHI extension analyses, reinforced the idea that vessel health at the time hormones are introduced changes how the body responds to them.

What the window looks like in practice

Most current guidance frames the window as starting hormone therapy under age 60 or within 10 years of your final menstrual period, whichever comes first. Within that window, research suggests hormone therapy may offer some cardiovascular benefit, in addition to relief from hot flashes, night sweats, and bone loss. Outside the window, cardiovascular risk appears to rise instead, and the case for starting therapy purely for prevention weakens - though treating disruptive symptoms is still sometimes reasonable with careful individual review.

Under 60 or within 10 years of menopause: the benefit-risk balance is generally most favorable for most healthy women.
10 or more years past menopause, or over 60: hormone therapy may still be an option for some symptoms, but the calculation shifts and needs closer individual review.
The window applies most clearly to systemic hormone therapy - vaginal estrogen for local symptoms carries a different, generally lower-risk profile at any age.

Why this shows up in the 2026 FDA labels

The FDA's finalized 2026 label changes explicitly incorporate age-specific guidance, a direct result of the timing hypothesis research reviewed by the July 2025 expert panel. That's a meaningful shift from the original one-size-fits-all boxed warning, which didn't distinguish a 51-year-old starting HRT for hot flashes from a 70-year-old starting it for the first time.

What this means if you're outside the window

"Outside the window" doesn't automatically mean no. Some women who missed the typical starting window still have symptoms significant enough that a doctor may consider hormone therapy after weighing personal risk factors, or may recommend non-hormonal options instead. This is a genuinely individual decision, not a fixed rule.

When to see a doctor

You're within a few years of your last period and wondering whether now is the right time to start hormone therapy.
You're over 60, or more than 10 years past menopause, and want to know what your options look like given the timing research.

Frequently asked questions

What is the HRT window of opportunity?: It's the period - generally under age 60 or within 10 years of your final period - during which starting hormone therapy is associated with the most favorable balance of symptom relief and cardiovascular risk, based on re-analysis of WHI data and later research.
Is 60 too old to start HRT?: Sixty isn't an automatic cutoff, but it's the age most guidance uses as one edge of the favorable window. Starting after 60 doesn't rule out hormone therapy, but it does mean a doctor will weigh cardiovascular and other risk factors more carefully before prescribing.
What happens if you start HRT late?: Starting more than about 10 years after menopause is associated with a less favorable cardiovascular risk profile than starting earlier, based on the timing hypothesis research. It doesn't mean HRT is off the table, but the decision needs more individualized review of your health history.